SENSEONICSHOLDINGS,INC. (NYSEMKT:SENS) Files An 8-K Results of Operations and Financial Condition

Item 2.02.Results of Operations and Financial Condition.

On February 23, 2017, Senseonics Holdings, Inc. (the Company)
issued a press release announcing its financial results for the
quarter and year endedDecember 31, 2016, as well as information
regarding a conference call to discuss these financial results
and the Companys recent corporate highlights and outlook.This
press release has been furnished as Exhibit 99.1 to this Current
Report on Form 8-K and is incorporated herein by this reference.

The information in this Current Report on Form 8-K, including
Exhibit 99.1 attached hereto, is being furnished and shall not be
deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the Exchange Act) or otherwise
subject to the liabilities of that section. The information
contained herein and in the accompanying exhibit is not
incorporated by reference in any filing of the Company under the
Securities Act of 1933, as amended, or the Exchange Act, whether
made before or after the date hereof and irrespective of any
general incorporation language in any filings.

Item 9.01.Financial Statements and Exhibits.

(d)Exhibits.

About SENSEONICS HOLDINGS, INC. (NYSEMKT:SENS)

Senseonics Holdings, Inc., formerly ASN Technologies, Inc., is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days. Eversense consists of three components: a small sensor inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user’s mobile device, such as a smartphone, Apple Watch or tablet.

SENSEONICS HOLDINGS, INC. (NYSEMKT:SENS) Recent Trading Information

SENSEONICS HOLDINGS, INC. (NYSEMKT:SENS) closed its last trading session 00.00 at 2.32 with 121,088 shares trading hands.